Published in Menopause on March 01, 2010
Dietary and botanical anxiolytics. Med Sci Monit (2012) 0.79
Critical appraisal of paroxetine for the treatment of vasomotor symptoms. Int J Womens Health (2015) 0.75
Estrogen, cognition and female ageing. Hum Reprod Update (2006) 1.78
Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women. J Hypertens (2003) 1.49
Non-genomic actions of sex steroid hormones. Eur J Endocrinol (2003) 1.48
Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application. Menopause (2007) 1.47
Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway. Mol Endocrinol (2006) 1.35
Single serum activin a testing to predict ectopic pregnancy. J Clin Endocrinol Metab (2007) 1.15
Endometrial expression and secretion of activin A, but not follistatin, increase in the secretory phase of the menstrual cycle. J Soc Gynecol Investig (2003) 1.12
Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene. Circulation (2002) 1.11
Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum Reprod (2007) 1.08
Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm. J Endocrinol (2008) 1.08
Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton. PLoS One (2008) 1.08
Kallmann syndrome in women: from genes to diagnosis and treatment. Gynecol Endocrinol (2013) 1.02
Serum and tissue expression of activin a in postmenopausal women with breast cancer. J Clin Endocrinol Metab (2002) 1.02
Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Arch Gynecol Obstet (2011) 1.01
Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system. Interaction of estrogen receptor alpha with phosphatidylinositol 3-OH kinase. Steroids (2002) 0.98
Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome. Psychoneuroendocrinology (2010) 0.98
Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase. Endocr Relat Cancer (2010) 0.97
Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology (2003) 0.97
Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology (2004) 0.96
Compensatory feto-placental upregulation of the nitric oxide system during fetal growth restriction. PLoS One (2012) 0.95
Effects in postmenopausal women of estradiol and medroxyprogesterone alone and combined on resistance artery function and endothelial morphology and movement. J Clin Endocrinol Metab (2008) 0.95
Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril (2008) 0.95
Endocrinology of menopausal transition and its brain implications. CNS Spectr (2005) 0.93
Listeriosis in pregnancy: a case report. J Matern Fetal Neonatal Med (2005) 0.91
Progestogens regulate endothelial actin cytoskeleton and cell movement via the actin-binding protein moesin. Mol Hum Reprod (2008) 0.90
Conjugated equine estrogens reverse the effects of aging on central and peripheral allopregnanolone and beta-endorphin levels in female rats. Fertil Steril (2004) 0.90
An unusual association: anomalous origin of the left pulmonary artery from the thoracic aorta with total anomalous venous return of the left lung. Pediatr Cardiol (2010) 0.88
Neuroendocrine aspects of placenta and pregnancy. Gynecol Endocrinol (2012) 0.88
Follicular fluid VEGF levels directly correlate with perifollicular blood flow in normoresponder patients undergoing IVF. J Assist Reprod Genet (2008) 0.88
Female infertility related to thyroid autoimmunity: the ovarian follicle hypothesis. Am J Reprod Immunol (2011) 0.88
P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel- plus platinum-based chemotherapy and long-term clinical outcome. Anticancer Res (2006) 0.87
Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women. Maturitas (2003) 0.87
Sumatriptan (50 mg tablets vs. 25 mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptive-induced menstrual migraine: a pilot study. Gynecol Endocrinol (2010) 0.86
Maternal dietary habits and mycotoxin occurrence in human mature milk. Mol Nutr Food Res (2008) 0.86
Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome. Gynecol Endocrinol (2009) 0.86
Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women. Gynecol Endocrinol (2006) 0.85
Genomic and nongenomic mechanisms of nitric oxide synthesis induction in human endothelial cells by a fourth-generation selective estrogen receptor modulator. Endocrinology (2002) 0.84
Endometriosis-Associated Abdominal Wall Cancer: A Poor Prognosis? Int J Gynecol Cancer (2015) 0.84
Paracrine regulation of endometrial function: interaction between progesterone and corticotropin-releasing factor (CRF) and activin A. Steroids (2003) 0.83
Self-reported sexual symptoms in women attending menopause clinics. Gynecol Obstet Invest (2002) 0.83
Low serum and peritoneal fluid concentration of interferon-gamma-induced protein-10 (CXCL10) in women with endometriosis. Fertil Steril (2008) 0.83
Might DHEA be considered a beneficial replacement therapy in the elderly? Drugs Aging (2007) 0.83
Pregnancy complications in polycystic ovary syndrome patients. Gynecol Endocrinol (2014) 0.83
An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing. Eur J Obstet Gynecol Reprod Biol (2008) 0.83
Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids. Fertil Steril (2003) 0.83
Allopregnanolone serum levels and expression of 5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase isoforms in hippocampal and temporal cortex of patients with epilepsy. Epilepsy Res (2003) 0.83
Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis. Fertil Steril (2007) 0.83
Increased plasma concentrations of activin a predict intraventricular hemorrhage in preterm newborns. Clin Chem (2006) 0.82
Activin A in brain injury. Adv Clin Chem (2007) 0.82
Sex steroids and breast cancer metastasis. Horm Mol Biol Clin Investig (2010) 0.82
Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism. Maturitas (2006) 0.82
Yolk sac tumor in a young girl: a case report. Gynecol Endocrinol (2005) 0.82
Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels. Neuroendocrinology (2006) 0.82
Maternal position during non-stress test and fetal heart rate patterns. Acta Obstet Gynecol Scand (2005) 0.82
High urinary concentrations of activin A in asphyxiated full-term newborns with moderate or severe hypoxic ischemic encephalopathy. Clin Chem (2007) 0.82
Sexual hormone serum levels and temporomandibular disorders. A preliminary study. Gynecol Endocrinol (2005) 0.81
Maternal serum inhibin A levels may predict pregnancy outcome in women with threatened abortion. Fertil Steril (2004) 0.81
Effects of oral contraceptives on bone mineral density. Treat Endocrinol (2004) 0.81
Effect of dehydroepiandrosterone on central and peripheral levels of allopregnanolone and beta-endorphin. Fertil Steril (2005) 0.81
Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women. Maturitas (2005) 0.81
Pulsatile secretory characteristics of allopregnanolone, a neuroactive steroid, during the menstrual cycle and in amenorrheic subjects. Eur J Endocrinol (2002) 0.81
Serum activin A levels are lower in tubal than intrauterine spontaneously conceived pregnancies. Gynecol Endocrinol (2011) 0.80
Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activity. Psychoneuroendocrinology (2010) 0.80
Androgens and the brain. Maturitas (2007) 0.80
The metabolic syndrome and its components in postmenopausal women. Gynecol Endocrinol (2013) 0.80
Serum allopregnanolone levels relate to FSFI score during the menstrual cycle. J Sex Marital Ther (2003) 0.80
Effect of tibolone administration on central and peripheral levels of allopregnanolone and beta-endorphin in female rats. Menopause (2006) 0.80
Activation of nitric oxide synthesis in human endothelial cells by red clover extracts. Menopause (2005) 0.80
Effects of phytoestrogens derived from red clover on atherogenic adhesion molecules in human endothelial cells. Menopause (2008) 0.80
Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with nonobese healthy controls and non-binge eating obese subjects. Int J Eat Disord (2003) 0.80